Company / Total Assets
Praxis Precision Medicines, Inc. Total Assets History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$937.9M
FY2025
5-year range
$87.9M / $937.9M
FY2021-FY2025
Trend
+94.1%
vs FY2024
Sector context
#85 of 214
Health Care
What the data says
At $938M, Praxis Precision Medicines, Inc.'s total assets ranks #85 of 214 in the Health Care sector. Improved from $88M to $938M over the past 2 years.
Based on SEC 10-K filings.
$938M in FY2025 with a 5-year CAGR of +25.3%.
Improved from $88M to $938M over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +101.2%
- 5-Year CAGR
- +25.3%
- 10-Year CAGR
- -
Sector benchmark
#85 of 214 in Health CareTop 40% of 214This company $937.9M Sector average $7.5B
▼
-87.4% below sector average
Key checks
Key Insights
- 5-year CAGR of +25.3%, indicating consistent growth.
- In FY2025, total assets increased 94.1% year-over-year.
- Ranks #85 out of 214 companies in the Health Care sector.
- Lowest total assets in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 4.48 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $937.9M | +94.1% |
| FY2024 | $483.1M | +449.3% |
| FY2023 | $87.9M | -23.6% |
| FY2022 | $115.1M | -60.7% |
| FY2021 | $292.7M | -3.4% |
| FY2020 | $303.2M | +535.7% |
| FY2019 | $47.7M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026